- About Us
- Reproductive Health & Pregnancy Therapeutics
- Our Pipeline
- News & Events
At ObsEva, our passion and expertise in reproductive health and pregnancy therapeutics is helping millions of women worldwide lead healthier and more fulfilling lives.
Millions of women worldwide suffer from reproductive health conditions that affect their quality of life or ability to conceive and may lead to complications during pregnancy.
ObsEva is advancing a robust pipeline of novel, orally-administered, clinical-stage compounds in the areas of uterine fibroids, endometriosis, assisted reproductive technology, and preterm labor.
ObsEva SA Initiates Phase 3 Clinical Program for OBE2109 in Uterine FibroidsRead More
ObsEva SA to Attend Needham Annual Healthcare Conference in NYCRead More
ObsEva to Present Pharmacology Results Demonstrating OBE022 Exerts a Synergistic Effect in Combination with Standard of Care in Animal Model for Preterm LaborRead More
ObsEva Starts Phase 3 Clinical Program for Nolasiban in ARTRead More